NeoGenomics (NEO)
Runs cancer diagnostic laboratories serving community oncologists, pathologists, and pharmaceutical trial sponsors.
$18.79
vs last close−0.10 (−0.53%)
Something off on this page? Send us feedback.
Next report
Oct 27, 26
in 34 days
EPS estimate
$0.06
Revenue estimate
$205.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$0.04−$0.08$0.03$0.03$0.06$0.01$0.05Pending
Estimate$0.03−$0.02$0.03$0.02$0.04$0.01$0.03$0.06
Surprise+33.3%−300.0%0.0%+50.0%+50.0%+73.0%+49.0%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$172.0M$168.0M$181.3M$187.8M$190.2M$186.7M$201.7MPending
Estimate$172.6M$182.9M$183.9M$188.2M$188.5M$184.5M$196.9M$205.9M
Surprise−0.3%−8.1%−1.4%−0.2%+0.9%+1.2%+2.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.16 | — | — |
| Sep 2028 | $0.09 | — | — |
| Jun 2028 | $0.13 | — | — |
| Mar 2028 | $0.08 | — | — |
| Dec 2027 | $0.13 | — | — |
| Sep 2027 | $0.09 | — | — |
| Jun 2027 | $0.09 | — | — |
| Mar 2027 | $0.07 | — | — |
| Dec 2026 | $0.07 | — | — |
| Oct 2026 | $0.06 | — | — |
| Jul 2026 | $0.03 | $0.05 | +49.0% |
| Apr 2026 | $0.01 | $0.01 | +73.0% |
| Feb 2026 | $0.04 | $0.06 | +50.0% |
| Oct 2025 | $0.02 | $0.03 | +50.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Mar 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.16 | — | — | $252.5M | — | — | — |
| Sep 2028 | $0.09 | — | — | $246.5M | — | — | — |
| Jun 2028 | $0.13 | — | — | $242.3M | — | — | — |
| Mar 2028 | $0.08 | — | — | $223.8M | — | — | — |
| Dec 2027 | $0.13 | — | — | $230.7M | — | — | — |
| Sep 2027 | $0.09 | — | — | $225.2M | — | — | — |
| Jun 2027 | $0.09 | — | — | $221.1M | — | — | — |
| Mar 2027 | $0.07 | — | — | $207.1M | — | — | — |
| Dec 2026 | $0.07 | — | — | $209.9M | — | — | — |
| Oct 27, 2026 | $0.06 | — | — | $205.9M | — | — | — |
| Jul 28, 2026 | $0.03 | $0.05 | +49.0% | $196.9M | $201.7M | +2.4% | +14.0% |
| Apr 28, 2026 | $0.01 | $0.01 | +73.0% | $184.5M | $186.7M | +1.2% | −0.7% |
| Feb 17, 2026 | $0.04 | $0.06 | +50.0% | $188.5M | $190.2M | +0.9% | +0.5% |
| Oct 28, 2025 | $0.02 | $0.03 | +50.0% | $188.2M | $187.8M | −0.2% | −2.4% |
| Jul 29, 2025 | |||||||
| Apr 29, 2025 | |||||||
| Feb 18, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Jul 29, 2024 | |||||||
| Apr 30, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Oct 27, 2020 | |||||||
| Jul 28, 2020 | |||||||
| Apr 28, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Oct 29, 2019 | |||||||
| Jul 30, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Feb 19, 2019 | |||||||
| Oct 30, 2018 | |||||||
| Jul 24, 2018 | |||||||
| May 1, 2018 | |||||||
| Feb 21, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 25, 2017 | |||||||
| Apr 26, 2017 | |||||||
| Feb 22, 2017 | |||||||
| Oct 26, 2016 | |||||||
| Jul 26, 2016 | |||||||
| Apr 27, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Oct 29, 2015 | |||||||
| Jul 23, 2015 |